{"id":"tp-28101","type":"article-newspaper","title":"Iambic Therapeutics Plans Nasdaq IPO Above $800 Million Valuation","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/28101","datePublished":"2026-10-08T13:25:04.000Z","dateModified":"2026-10-08T13:25:04.000Z","language":"en","abstract":"The Nvidia- and AbbVie-backed life sciences company plans to list under the ticker IAM and leverages artificial intelligence.","section":"Business","references":[]}